Physician profile
Christopher J Barde
NPI 1215918263
$4,616.53
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,206 · 2020: $546 · 2021: $1,480 · 2022: $1,122 · 2023: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $262.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,450.10 | 2019-2023 | Rinvoq, Humira |
| Pfizer INC. | $821.45 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $726.57 | 2019-2022 | |
| Qol Medical, LLC | $265.89 | 2021-2022 | |
| Evoke Pharma, INC. | $166.28 | 2022-2023 | Gimoti |
| Daiichi Sankyo INC. | $152.71 | 2019-2022 | |
| Ethicon US, LLC | $139.51 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $124.99 | 2019 | |
| Janssen Biotech, INC. | $102.82 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $100.64 | 2019-2022 | |
| Celgene Corporation | $98.10 | 2021-2022 | |
| Redhill Biopharma INC. | $77.69 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $75.65 | 2020-2021 | |
| Genzyme Corporation | $54.17 | 2023 | |
| Merck Sharp & Dohme LLC | $44.00 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $43.96 | 2019-2023 | |
| Intercept Pharmaceuticals, INC. | $37.12 | 2019-2023 | Ocaliva |
| Braintree Laboratories, INC. | $33.95 | 2021-2023 | Suflave |
| Ironwood Pharmaceuticals, INC | $29.08 | 2019-2021 | |
| Vivus LLC | $24.05 | 2020 | |
| Amgen INC. | $13.47 | 2022 | |
| Shionogi INC | $11.68 | 2019 | |
| Nestle Healthcare Nutrition INC. | $11.55 | 2021 | |
| Endo Pharmaceuticals INC. | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Barde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.